Clopidogrel, sold as the brandname Plavix among others, is an antiplatelet medication that is used to reduce the risk of heart disease and stroke in those at high risk. It is also used together with aspirin in heart attacks and following the placement of a coronary artery stent. It is taken by mouth.
Clopidogrel has remained, ever since its first approval in 1997, the antiplatelet therapy of choice among physicians for the treatment of patients with conditions such as acute coronary syndrome or percutaneous coronary intervention. The drug was the first thienopyridine to hit the market, which gave it an excellent head start over a number of drugs for these conditions that are either available in the market or are in clinical trials. As a result, the drug did not face much competition and has taken over the global market, with its array of application constantly expanding.
Market Analysis and Insights: Global Clopidogrel Market
The global Clopidogrel market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Clopidogrel Scope and Segment
The global Clopidogrel market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Clopidogrel market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
25mg
75 mg
300 mg
By the end users/application, this report covers the following segments
Hospitals
Private Clinics
Retail Pharmacies
Online Pharmacies
Others
Competitive Landscape:
The report provides a list of all the key players in the Clopidogrel market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Clopidogrel key manufacturers in this market include:
Sanofi (France)
Shenzhen Salubris Pharmaceuticals (China)
Lepu Medical Technology (China)
Clopidogrel has remained, ever since its first approval in 1997, the antiplatelet therapy of choice among physicians for the treatment of patients with conditions such as acute coronary syndrome or percutaneous coronary intervention. The drug was the first thienopyridine to hit the market, which gave it an excellent head start over a number of drugs for these conditions that are either available in the market or are in clinical trials. As a result, the drug did not face much competition and has taken over the global market, with its array of application constantly expanding.
Market Analysis and Insights: Global Clopidogrel Market
The global Clopidogrel market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Clopidogrel Scope and Segment
The global Clopidogrel market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Clopidogrel market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
25mg
75 mg
300 mg
By the end users/application, this report covers the following segments
Hospitals
Private Clinics
Retail Pharmacies
Online Pharmacies
Others
Competitive Landscape:
The report provides a list of all the key players in the Clopidogrel market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Clopidogrel key manufacturers in this market include:
Sanofi (France)
Shenzhen Salubris Pharmaceuticals (China)
Lepu Medical Technology (China)
1 Clopidogrel Market Overview
1.1 Clopidogrel Product Overview
1.2 Clopidogrel Market Segment by Type
1.2.1 25mg
1.2.2 75 mg
1.2.3 300 mg
1.3 Global Clopidogrel Market Size by Type
1.3.1 Global Clopidogrel Market Size Overview by Type (2016-2027)
1.3.2 Global Clopidogrel Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Clopidogrel Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Clopidogrel Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Clopidogrel Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Clopidogrel Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Clopidogrel Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Clopidogrel Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Clopidogrel Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Clopidogrel Sales Breakdown by Type (2016-2021)
1.4.2 Europe Clopidogrel Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Clopidogrel Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Clopidogrel Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Clopidogrel Sales Breakdown by Type (2016-2021)
2 Global Clopidogrel Market Competition by Company
2.1 Global Top Players by Clopidogrel Sales (2016-2021)
2.2 Global Top Players by Clopidogrel Revenue (2016-2021)
2.3 Global Top Players Clopidogrel Price (2016-2021)
2.4 Global Top Manufacturers Clopidogrel Manufacturing Base Distribution, Sales Area, Product Type
2.5 Clopidogrel Market Competitive Situation and Trends
2.5.1 Clopidogrel Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Clopidogrel Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Clopidogrel as of 2020)
2.7 Date of Key Manufacturers Enter into Clopidogrel Market
2.8 Key Manufacturers Clopidogrel Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Clopidogrel Status and Outlook by Region
3.1 Global Clopidogrel Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Clopidogrel Historic Market Size by Region
3.2.1 Global Clopidogrel Sales in Volume by Region (2016-2021)
3.2.2 Global Clopidogrel Sales in Value by Region (2016-2021)
3.2.3 Global Clopidogrel Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Clopidogrel Forecasted Market Size by Region
3.3.1 Global Clopidogrel Sales in Volume by Region (2022-2027)
3.3.2 Global Clopidogrel Sales in Value by Region (2022-2027)
3.3.3 Global Clopidogrel Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Clopidogrel by Application
4.1 Clopidogrel Market Segment by Application
4.1.1 Hospitals
4.1.2 Private Clinics
4.1.3 Retail Pharmacies
4.1.4 Online Pharmacies
4.1.5 Others
4.2 Global Clopidogrel Market Size by Application
4.2.1 Global Clopidogrel Market Size Overview by Application (2016-2027)
4.2.2 Global Clopidogrel Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Clopidogrel Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Clopidogrel Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Clopidogrel Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Clopidogrel Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Clopidogrel Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Clopidogrel Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Clopidogrel Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Clopidogrel Sales Breakdown by Application (2016-2021)
4.3.2 Europe Clopidogrel Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Clopidogrel Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Clopidogrel Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Clopidogrel Sales Breakdown by Application (2016-2021)
5 North America Clopidogrel by Country
5.1 North America Clopidogrel Historic Market Size by Country
5.1.1 North America Clopidogrel Sales in Volume by Country (2016-2021)
5.1.2 North America Clopidogrel Sales in Value by Country (2016-2021)
5.2 North America Clopidogrel Forecasted Market Size by Country
5.2.1 North America Clopidogrel Sales in Volume by Country (2022-2027)
5.2.2 North America Clopidogrel Sales in Value by Country (2022-2027)
6 Europe Clopidogrel by Country
6.1 Europe Clopidogrel Historic Market Size by Country
6.1.1 Europe Clopidogrel Sales in Volume by Country (2016-2021)
6.1.2 Europe Clopidogrel Sales in Value by Country (2016-2021)
6.2 Europe Clopidogrel Forecasted Market Size by Country
6.2.1 Europe Clopidogrel Sales in Volume by Country (2022-2027)
6.2.2 Europe Clopidogrel Sales in Value by Country (2022-2027)
7 Asia-Pacific Clopidogrel by Region
7.1 Asia-Pacific Clopidogrel Historic Market Size by Region
7.1.1 Asia-Pacific Clopidogrel Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Clopidogrel Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Clopidogrel Forecasted Market Size by Region
7.2.1 Asia-Pacific Clopidogrel Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Clopidogrel Sales in Value by Region (2022-2027)
8 Latin America Clopidogrel by Country
8.1 Latin America Clopidogrel Historic Market Size by Country
8.1.1 Latin America Clopidogrel Sales in Volume by Country (2016-2021)
8.1.2 Latin America Clopidogrel Sales in Value by Country (2016-2021)
8.2 Latin America Clopidogrel Forecasted Market Size by Country
8.2.1 Latin America Clopidogrel Sales in Volume by Country (2022-2027)
8.2.2 Latin America Clopidogrel Sales in Value by Country (2022-2027)
9 Middle East and Africa Clopidogrel by Country
9.1 Middle East and Africa Clopidogrel Historic Market Size by Country
9.1.1 Middle East and Africa Clopidogrel Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Clopidogrel Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Clopidogrel Forecasted Market Size by Country
9.2.1 Middle East and Africa Clopidogrel Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Clopidogrel Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Clopidogrel Business
10.1 Sanofi (France)
10.1.1 Sanofi (France) Corporation Information
10.1.2 Sanofi (France) Introduction and Business Overview
10.1.3 Sanofi (France) Clopidogrel Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Sanofi (France) Clopidogrel Products Offered
10.1.5 Sanofi (France) Recent Development
10.2 Shenzhen Salubris Pharmaceuticals (China)
10.2.1 Shenzhen Salubris Pharmaceuticals (China) Corporation Information
10.2.2 Shenzhen Salubris Pharmaceuticals (China) Introduction and Business Overview
10.2.3 Shenzhen Salubris Pharmaceuticals (China) Clopidogrel Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Sanofi (France) Clopidogrel Products Offered
10.2.5 Shenzhen Salubris Pharmaceuticals (China) Recent Development
10.3 Lepu Medical Technology (China)
10.3.1 Lepu Medical Technology (China) Corporation Information
10.3.2 Lepu Medical Technology (China) Introduction and Business Overview
10.3.3 Lepu Medical Technology (China) Clopidogrel Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Lepu Medical Technology (China) Clopidogrel Products Offered
10.3.5 Lepu Medical Technology (China) Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Clopidogrel Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Clopidogrel Industrial Chain Analysis
11.4 Clopidogrel Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Clopidogrel Distributors
12.3 Clopidogrel Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Clopidogrel Product Overview
1.2 Clopidogrel Market Segment by Type
1.2.1 25mg
1.2.2 75 mg
1.2.3 300 mg
1.3 Global Clopidogrel Market Size by Type
1.3.1 Global Clopidogrel Market Size Overview by Type (2016-2027)
1.3.2 Global Clopidogrel Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Clopidogrel Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Clopidogrel Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Clopidogrel Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Clopidogrel Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Clopidogrel Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Clopidogrel Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Clopidogrel Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Clopidogrel Sales Breakdown by Type (2016-2021)
1.4.2 Europe Clopidogrel Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Clopidogrel Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Clopidogrel Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Clopidogrel Sales Breakdown by Type (2016-2021)
2 Global Clopidogrel Market Competition by Company
2.1 Global Top Players by Clopidogrel Sales (2016-2021)
2.2 Global Top Players by Clopidogrel Revenue (2016-2021)
2.3 Global Top Players Clopidogrel Price (2016-2021)
2.4 Global Top Manufacturers Clopidogrel Manufacturing Base Distribution, Sales Area, Product Type
2.5 Clopidogrel Market Competitive Situation and Trends
2.5.1 Clopidogrel Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Clopidogrel Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Clopidogrel as of 2020)
2.7 Date of Key Manufacturers Enter into Clopidogrel Market
2.8 Key Manufacturers Clopidogrel Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Clopidogrel Status and Outlook by Region
3.1 Global Clopidogrel Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Clopidogrel Historic Market Size by Region
3.2.1 Global Clopidogrel Sales in Volume by Region (2016-2021)
3.2.2 Global Clopidogrel Sales in Value by Region (2016-2021)
3.2.3 Global Clopidogrel Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Clopidogrel Forecasted Market Size by Region
3.3.1 Global Clopidogrel Sales in Volume by Region (2022-2027)
3.3.2 Global Clopidogrel Sales in Value by Region (2022-2027)
3.3.3 Global Clopidogrel Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Clopidogrel by Application
4.1 Clopidogrel Market Segment by Application
4.1.1 Hospitals
4.1.2 Private Clinics
4.1.3 Retail Pharmacies
4.1.4 Online Pharmacies
4.1.5 Others
4.2 Global Clopidogrel Market Size by Application
4.2.1 Global Clopidogrel Market Size Overview by Application (2016-2027)
4.2.2 Global Clopidogrel Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Clopidogrel Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Clopidogrel Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Clopidogrel Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Clopidogrel Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Clopidogrel Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Clopidogrel Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Clopidogrel Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Clopidogrel Sales Breakdown by Application (2016-2021)
4.3.2 Europe Clopidogrel Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Clopidogrel Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Clopidogrel Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Clopidogrel Sales Breakdown by Application (2016-2021)
5 North America Clopidogrel by Country
5.1 North America Clopidogrel Historic Market Size by Country
5.1.1 North America Clopidogrel Sales in Volume by Country (2016-2021)
5.1.2 North America Clopidogrel Sales in Value by Country (2016-2021)
5.2 North America Clopidogrel Forecasted Market Size by Country
5.2.1 North America Clopidogrel Sales in Volume by Country (2022-2027)
5.2.2 North America Clopidogrel Sales in Value by Country (2022-2027)
6 Europe Clopidogrel by Country
6.1 Europe Clopidogrel Historic Market Size by Country
6.1.1 Europe Clopidogrel Sales in Volume by Country (2016-2021)
6.1.2 Europe Clopidogrel Sales in Value by Country (2016-2021)
6.2 Europe Clopidogrel Forecasted Market Size by Country
6.2.1 Europe Clopidogrel Sales in Volume by Country (2022-2027)
6.2.2 Europe Clopidogrel Sales in Value by Country (2022-2027)
7 Asia-Pacific Clopidogrel by Region
7.1 Asia-Pacific Clopidogrel Historic Market Size by Region
7.1.1 Asia-Pacific Clopidogrel Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Clopidogrel Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Clopidogrel Forecasted Market Size by Region
7.2.1 Asia-Pacific Clopidogrel Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Clopidogrel Sales in Value by Region (2022-2027)
8 Latin America Clopidogrel by Country
8.1 Latin America Clopidogrel Historic Market Size by Country
8.1.1 Latin America Clopidogrel Sales in Volume by Country (2016-2021)
8.1.2 Latin America Clopidogrel Sales in Value by Country (2016-2021)
8.2 Latin America Clopidogrel Forecasted Market Size by Country
8.2.1 Latin America Clopidogrel Sales in Volume by Country (2022-2027)
8.2.2 Latin America Clopidogrel Sales in Value by Country (2022-2027)
9 Middle East and Africa Clopidogrel by Country
9.1 Middle East and Africa Clopidogrel Historic Market Size by Country
9.1.1 Middle East and Africa Clopidogrel Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Clopidogrel Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Clopidogrel Forecasted Market Size by Country
9.2.1 Middle East and Africa Clopidogrel Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Clopidogrel Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Clopidogrel Business
10.1 Sanofi (France)
10.1.1 Sanofi (France) Corporation Information
10.1.2 Sanofi (France) Introduction and Business Overview
10.1.3 Sanofi (France) Clopidogrel Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Sanofi (France) Clopidogrel Products Offered
10.1.5 Sanofi (France) Recent Development
10.2 Shenzhen Salubris Pharmaceuticals (China)
10.2.1 Shenzhen Salubris Pharmaceuticals (China) Corporation Information
10.2.2 Shenzhen Salubris Pharmaceuticals (China) Introduction and Business Overview
10.2.3 Shenzhen Salubris Pharmaceuticals (China) Clopidogrel Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Sanofi (France) Clopidogrel Products Offered
10.2.5 Shenzhen Salubris Pharmaceuticals (China) Recent Development
10.3 Lepu Medical Technology (China)
10.3.1 Lepu Medical Technology (China) Corporation Information
10.3.2 Lepu Medical Technology (China) Introduction and Business Overview
10.3.3 Lepu Medical Technology (China) Clopidogrel Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Lepu Medical Technology (China) Clopidogrel Products Offered
10.3.5 Lepu Medical Technology (China) Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Clopidogrel Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Clopidogrel Industrial Chain Analysis
11.4 Clopidogrel Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Clopidogrel Distributors
12.3 Clopidogrel Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
